Sadiq Khan - 27 Jun 2025 Form 4 Insider Report for Tevogen Bio Holdings Inc. (TVGN)

Role: Chief Commercial Officer
Signature: /s/ Kirti Desai, Attorney-in-Fact
Issuer symbol: TVGN
Transactions as of: 27 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 01 Jul 2025, 16:49:18 UTC
Previous filing: 16 Feb 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Khan Sadiq	Chief Commercial Officer	C/O TEVOGEN BIO HOLDINGS INC., 15 INDEPENDENCE BLVD, STE 210, WARREN	/s/ Kirti Desai, Attorney-in-Fact	01 Jul 2025	0002011764

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TVGN	Common Stock	Award	$0	+200,000	+21%	$0.000000	1,169,618	27 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on June 27, 2030, provided that the reporting person remains in service with the Issuer at such dates.